One such condition can develop in patients with HAE, a life-threatening disease caused by the deficiency of C1-INH, the natural inhibitor of MASP-1, where MASP-1—due to its permeability increasing effect—may act as a potential triggering factor of edematous attacks. Here, MASP1 is linked to hereditary angioedema.